S. Rose‐John

Oncology · 2000–2018

A researcher in the Science corpus: 16 papers; trusts 9 researchers and is trusted by 20 researchers here, as inferred from the citation graph.

Subfields

• Oncology — 73 citations into it; #98 of 1,698 by trust here, #123 by citations
• Immunology — 71 citations into it; #444 of 2,160 by trust here, #385 by citations
• Cancer Research — 18 citations into it; #1,734 of 1,780 by trust here, #478 by citations
• Pathology and Forensic Medicine — 10 citations into it
• Hematology — 8 citations into it
• Dermatology — 7 citations into it; #70 of 119 by trust here, #86 by citations

Whom S. Rose‐John trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Simon A. Jones
2. T. Kishimoto
3. J. Scheller
4. S. Grivennikov
5. D. Schmidt-Arras
6. T. Waldmann
7. E. Bettelli

Who trusts S. Rose‐John overall

1. Simon A. Jones
2. Wan-Wan Lin
3. Christian K. Roberts
4. M. Karin
5. Neeraj Kumari
6. Shinwan Kany
7. J. Scheller
8. Yun-zi Liu
9. Christine L. Ferguson
10. M. Donath

Papers from S. Rose‐John's perspective

Ordered by how strongly the researchers S. Rose‐John trusts endorse each paper. Same corpus, a different order for every researcher.

1. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. (Cancer Cell)
2. Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous system (Nature Immunology)
3. STATs in cancer inflammation and immunity: a leading role for STAT3 (Nature Reviews. Cancer)
4. Interleukin‐6 biology is coordinated by membrane‐bound and soluble receptors: role in inflammation and cancer (Journal of Leukocyte Biology)
5. Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells (Science)
6. Humanized anti-interleukin-6 receptor antibody
7. cis Elements of the Villin Gene Control Expression in Restricted Domains of the Vertical (Crypt) and Horizontal (Duodenum, Cecum) Axes of the Intestine* (Journal of Biological Chemistry)
8. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens (Nature Medicine)
9. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. (Immunity)
10. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. (Biochemical Journal)

Their papers

• TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling (2004) — 676 citations
• Interleukin-6 Family Cytokines. (2018) — 700 citations
• IL-6 pathway in the liver: From physiopathology to therapy. (2016) — 821 citations
• Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T cell Therapy for Acute Lymphoblastic Leukemia (2016) — 965 citations
• A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. (2014) — 683 citations
• IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6 (2012) — 1,022 citations
• Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. (2011) — 849 citations
• The pro- and anti-inflammatory properties of the cytokine interleukin-6. (2011) — 3,213 citations
• Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. (2011) — 676 citations
• IL-6 and STAT3 are required for survival of intestinal epithelial cells and development of colitis associated cancer (2009) — 2,165 citations
• Interleukin‐6 biology is coordinated by membrane‐bound and soluble receptors: role in inflammation and cancer (2006) — 699 citations
• The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. (2003) — 741 citations
• Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. (2001) — 850 citations
• Structure of an Extracellular gp130 Cytokine Receptor Signaling Complex (2001) — 268 citations
• Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. (2001) — 651 citations
• Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo (2000) — 1,336 citations